# Single-Dose Intravesical Chemotherapy After Diagnostic URS

> **NCT05810623** · PHASE3 · NOT_YET_RECRUITING · sponsor: **David D'Andrea** · enrollment: 394 (estimated)

## Conditions studied

- Upper Urinary Tract Urothelial Carcinoma
- Bladder Cancer

## Interventions

- **DRUG:** Intravesical Solution

## Key facts

- **NCT ID:** NCT05810623
- **Lead sponsor:** David D'Andrea
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-06-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 394 (ESTIMATED)
- **Last updated:** 2023-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05810623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05810623, "Single-Dose Intravesical Chemotherapy After Diagnostic URS". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT05810623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*